Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ALS?src=hash" target="_blank"gt;#ALSlt;/agt;–Neuropore Therapies, Inc. announced today that it has initiated a Phase 1 clinical trial in healthy…
VIENNA, Va.–(BUSINESS WIRE)–The following letter was sent by CEL-SCI Corporation (NYSE American: CVM) to its shareholders: Dear CEL-SCI Shareholders: The…
LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, announced…
LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the leading provider of antibody discovery and optimization technology, today announced the expansion of an earlier…
Sixth pharma partner to internalize the Adimab platform LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the global leader in the discovery and optimization…
– Conference Call and Webcast Today, May 8, 2019, at 8:00 a.m. ET – NEW YORK–(BUSINESS WIRE)–IVERIC bio (Nasdaq: ISEE)…
— First-Quarter 2019 Net Sales of $280.4 Million Increased 25 Percent; First-Quarter 2019 GAAP Net Loss of $32.9 Million; Adjusted…
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR…
– Initiated Phase 1 Trial for FA “Process B” Using a Modified Cell Enrichment Process, Transduction Enhancers, and Commercial-Grade Vector…
— Companies to Pursue a Human Genetics Approach to Drug Discovery and Development — FOSTER CITY, Calif. & CAMBRIDGE, Mass.–(BUSINESS…